Detalhe da pesquisa
1.
Computed Tomography and Magnetic Resonance Imaging.
Recent Results Cancer Res
; 216: 31-110, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594384
2.
Computed tomography and magnetic resonance imaging.
Recent Results Cancer Res
; 187: 3-63, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23179877
3.
Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy response.
Theranostics
; 11(2): 491-505, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33391488
4.
Preclinical Efficacy and Safety Evaluation of Hematopoietic Stem Cell Gene Therapy in a Mouse Model of MNGIE.
Mol Ther Methods Clin Dev
; 8: 152-165, 2018 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29687034
5.
Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies.
EJNMMI Res
; 5(1): 62, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553049
6.
Magnetic Resonance Detection of CD34+ Cells from Umbilical Cord Blood Using a 19F Label.
PLoS One
; 10(9): e0138572, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26394043
7.
Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?
PLoS One
; 8(10): e77076, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24116203
8.
Facilitating tumor functional assessment by spatially relating 3D tumor histology and in vivo MRI: image registration approach.
PLoS One
; 6(8): e22835, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21897840